Clinical trial
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver…
NCT00056030 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00056030 |
|---|---|
| Title | Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer |
| Official title | A Phase II Study Of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), Leucovorin (CF), and Cetuximab (C225) For Patients With Unresectable Hepatic Metastases From Metastatic Adenocarcinoma Of The Colon Or Rectum |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Biological, Drug |
| Interventions | cetuximab, fluorouracil, leucovorin calcium, oxaliplatin |
| Enrollment | 73 |
| Start date | Dec 1, 2004 |
| Primary completion | Oct 1, 2007 |
| First posted | Mar 7, 2003 |
| Last update posted | Jan 24, 2017 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: